Insulin glargine biosimilar (Zhuhai United)

甘精胰岛素生物类似药 (珠海联邦)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInsulin glargine biosimilar (Zhuhai United)
Drug Alias NameInsulin glargine (Valin Technologies)甘精胰岛素生物仿制药 (Valin Technologies)
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsDiabetes Mellitus
Approved Indications in ChinaDiabetes Mellitus
Original Approved Country/TerritoryMainland China
Original Approved Date2016/12/23
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesZhuhai United Laboratories Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhuhai United Laboratories Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeA10AE04
Related LinksN/A